FRMD4A
FERM domain-containing protein 4A
Also known as: bA295P9.4, FLJ10210, FRM4A_HUMAN, FRMD4, KIAA1294
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9P2Q2
- Gene
- FRMD4A
- Ensembl
- ENSG00000151474
- Chromosome
- 10
- Canonical length
- 1039 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
This gene encodes a FERM domain-containing protein that regulates epithelial cell polarity. It connects ADP ribosylation factor 6 (ARF6) with the Par protein complex, which regulates the remodeling of adherens junctions and linear actin cable formation during epithelial cell polarization. Polymorphisms in this gene are associated with Alzheimer's disease, and also with nicotine dependence. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
1039 residues, UniProt reviewed canonical sequence.
>Q9P2Q2|FRMD4A
1 MAVQLVPDSA LGLLMMTEGR RCQVHLLDDR KLELLVQPKL LAKELLDLVA SHFNLKEKEY
61 FGIAFTDETG HLNWLQLDRR VLEHDFPKKS GPVVLYFCVR FYIESISYLK DNATIELFFL
121 NAKSCIYKEL IDVDSEVVFE LASYILQEAK GDFSSNEVVR SDLKKLPALP TQALKEHPSL
181 AYCEDRVIEH YKKLNGQTRG QAIVNYMSIV ESLPTYGVHY YAVKDKQGIP WWLGLSYKGI
241 FQYDYHDKVK PRKIFQWRQL ENLYFREKKF SVEVHDPRRA SVTRRTFGHS GIAVHTWYAC
301 PALIKSIWAM AISQHQFYLD RKQSKSKIHA ARSLSEIAID LTETGTLKTS KLANMGSKGK
361 IISGSSGSLL SSGSQESDSS QSAKKDMLAA LKSRQEALEE TLRQRLEELK KLCLREAELT
421 GKLPVEYPLD PGEEPPIVRR RIGTAFKLDE QKILPKGEEA ELERLEREFA IQSQITEAAR
481 RLASDPNVSK KLKKQRKTSY LNALKKLQEI ENAINENRIK SGKKPTQRAS LIIDDGNIAS
541 EDSSLSDALV LEDEDSQVTS TISPLHSPHK GLPPRPPSHN RPPPPQSLEG LRQMHYHRND
601 YDKSPIKPKM WSESSLDEPY EKVKKRSSHS HSSSHKRFPS TGSCAEAGGG SNSLQNSPIR
661 GLPHWNSQSS MPSTPDLRVR SPHYVHSTRS VDISPTRLHS LALHFRHRSS SLESQGKLLG
721 SENDTGSPDF YTPRTRSSNG SDPMDDCSSC TSHSSSEHYY PAQMNANYST LAEDSPSKAR
781 QRQRQRQRAA GALGSASSGS MPNLAARGGA GGAGGAGGGV YLHSQSQPSS QYRIKEYPLY
841 IEGGATPVVV RSLESDQEGH YSVKAQFKTS NSYTAGGLFK ESWRGGGGDE GDTGRLTPSR
901 SQILRTPSLG REGAHDKGAG RAAVSDELRQ WYQRSTASHK EHSRLSHTSS TSSDSGSQYS
961 TSSQSTFVAH SRVTRMPQMC KATSAALPQS QRSSTPSSEI GATPPSSPHH ILTWQTGEAT
1021 ENSPILDGSE SPPHQSTDELocalizationUniProt · AlphaFold · HPA
Whether an antibody against FRMD4A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 53 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 53 nTPM
- blood vessel: 28 nTPM
- skin: 26 nTPM
- spleen: 26 nTPM
- breast: 22 nTPM
- placenta: 20 nTPM
Single-cell type
- microglia: 6,042 nCPM
- oligodendrocytes: 1,922 nCPM
- brain inhibitory neurons: 1,641 nCPM
- brain excitatory neurons: 1,602 nCPM
- other brain neurons: 1,236 nCPM
- retinal ganglion cells: 1,147 nCPM
Immune cell
- naive B-cell: 2.3 nTPM
- memory B-cell: 0.8 nTPM
- plasmacytoid DC: 0.4 nTPM
- T-reg: 0.4 nTPM
- naive CD4 T-cell: 0.3 nTPM
- memory CD4 T-cell: 0.2 nTPM
Brain region
- basal ganglia: 271 nTPM
- cerebral cortex: 250 nTPM
- hippocampal formation: 237 nTPM
- white matter: 226 nTPM
- thalamus: 226 nTPM
- hypothalamus: 222 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FRMD4A.
Disease | AllUniProt
Conditions FRMD4A is implicated in, by any mechanism.
- Agenesis of the corpus callosum, with facial anomalies and cerebellar ataxia (CCAFCA) MIM:616819
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 266 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.14
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.46
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- establishment of epithelial cell polarity
- negative regulation of protein secretion
- positive regulation of protein secretion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- FERM domain
- PH-like domain superfamily
- FERM/acyl-CoA-binding protein superfamily
- FERM, N-terminal
- FERM, C-terminal PH-like domain
- FERM conserved site
- FERM central domain
- Band 4.1 domain
- Cytohesin Ubiquitin Protein Inducing Domain
- Ubiquitin-like domain superfamily
- FERM superfamily, second domain
- FRMD4A/B, FERM domain C-lobe
- FERM domain-containing protein 4A/B
- FERM central domain
- FERM N-terminal domain
- FERM C-terminal PH-like domain
- Cytohesin Ubiquitin Protein Inducing Domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FRMD4A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FRMD4A as an antibody target. Whether an autoantibody or antibody against FRMD4A could matter depends on whether native FRMD4A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FRMD4A is annotated at the cell surface, where native FRMD4A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FRMD4A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...